UBS Group Cuts Aemetis (NASDAQ:AMTX) Price Target to $2.20
Aemetis (NASDAQ:AMTX – Free Report) had its price objective reduced by UBS Group from $2.50 to $2.20 in a report issued on Friday,Benzinga reports. UBS Group currently has a buy rating on the specialty chemicals company’s stock. Several other equities analysts have also recently weighed in on the company. Ascendiant Capital Markets raised their price […]
Aemetis (NASDAQ:AMTX – Free Report) had its price objective reduced by UBS Group from $2.50 to $2.20 in a report issued on Friday,Benzinga reports. UBS Group currently has a buy rating on the specialty chemicals company’s stock. Several other equities analysts have also recently weighed in on the company. Ascendiant Capital Markets raised their price […]
